Skip to content

Foamstream offers landscapers a herbicide-free weed killing option

Since the nationwide controversy surrounding glyphosate and other chemical-based herbicides has yet to reach an end, the European company Weedingtech offered an herbicide-free weed treatment option at this year’s GIE+EXPO called Foamstream. “Whatever you think about the safety of glyphosate and herbicides, we don’t want to get drawn into that argument,” says Leo de Montaignac, CEO … Continued

ActiveOps selects Dallas as its US base

This summer UK based cloud computing company ActiveOps Ltd. acquired OpenConnect Inc., a Farmers Branch-based software provider, making Dallas a third U.S. office location for ActiveOps along with New York and Charlotte, North Carolina. The recent acquisition allows ActiveOps to combine its SaaS product called Workware with OpenConnect’s WorkiQ product, creating the Workware+ platform. ActiveOps describes … Continued

Arecor signs research, development and commercialisation agreement with JDRF

Arecor, the biopharmaceutical company advancing today’s therapies to enable healthier lives, has announced that it has signed a Research, Development and Commercialisation agreement with JDRF, the leading global organisation funding type 1 diabetes (T1D) research. Under this collaboration, Arecor and JDRF will contribute matching funds to develop a stable, liquid co-formulation of pramlintide and insulin … Continued

Calculus launches zero initial fee VCT offer – Limited time only

Normal initial fees of 3-5% waived until end of November Award-winning Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist, Calculus Capital, is waiving initial fees on its VCT until the end of November. The VCT is aiming to deliver an annual tax-free dividend of 4.5%, as well as capital growth. Earlier this year … Continued

Arecor: Dosing complete in Phase 1 clinical trial

Dosing complete in Phase 1 clinical trial of ultra-rapid acting insulin product candidate AT247 for Diabetes.  HEADLINE DATA READOUT EXPECTED Q4 2019 Calculus Capital portfolio company, Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, announced completion of dosing and all patient visits in its Phase I clinical trial … Continued

Calculus Capital finalists at the Tax Efficiency Awards 2019/20

Calculus Capital are delighted to be finalists in three categories at the upcoming Tax Efficiency Awards 2019/20. Best Generalist – EIS Best Generalist – VCT Exit of the Year The awards are designed to recognise the most successful and forward-thinking providers in the areas of VCTs, EIS and BPR/IHT. Winners will be announced on Friday … Continued

Genedrive gets approval to trial baby deafness test in NHS hospitals

Genedrive plc has received approval from the NHS Health Research Authority to start testing its Antibiotic Induced Hearing (AIHL) test in hospital trials. The AIHL test will be trialled in 1,000 patients from two large UK intensive care units in a study (PALOH) scheduled to start in November that will run for six months. This … Continued